- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Chest Tomosynthesis Shows Promise for Early Cancer Detection
Digital chest tomosynthesis used as a screening tool for lung cancer shows comparable rates of detection to low-dose CT.
Digital chest tomosynthesis (DT) detected a comparable number of noncalcified lung nodules as low-dose CT during lung cancer screening, according to a study published in the Journal of Thoracic Oncology.
Italian researchers conducted a single-arm observational study comparing the use of DT with CT in a population that was at risk for developing lung cancer. From December 2010 to December 2011, 1,843 patients were enrolled from an initial group of 1,919 candidates. They ranged in age from 48 to 73, with a mean age of 61. Seventy-seven percent were current smokers; the remaining had a history of at least 20-pack years, without malignancy in the previous five years before the study. DT was performed at baseline and again one year later.
The researchers found that DT detected pulmonary abnormalities in 268 subjects (14.5 percent) and first-line basal CT was subsequently carried out in 132 subjects (7.2 percent), 68 (4.9 percent) of which were referred for follow-up CT. Positron-emission tomography/CT was performed on 27 individuals (1.46 percent), and lung cancer was detected in 18 (0.98 percent) of them.
The authors concluded that the DT holds promise as use for first-line lung cancer screening, particularly because of its lower cost and the reduction of radiation dosages.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
